Lenti-Her2 TCR (H5)-VP(VP-TCR-C139)
The ready-to-use lentiviral particles of Lenti-Her2 TCR (H5)-VP is packaged using 3rd generation of lentiviral packaging system, in which the gene of Human TCR will be driven by a CMV promotor. The target gene of TCR packaged in lentiviral particles could be used for high efficency tranduction of T cells and stably integrated expression.
Specifications
Type of Therapeutics
T cell receptor
Packaging System
Lentivirus
Targeting Diseases
Breast cancer
Target
Introduction
This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized.
Alternative Names
NEU; NGL; HER2; TKR1; CD340; HER-2; MLN 19; HER-2/neu
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Related Products
| Cat# |
Description |
| OAdCmodV-YX1021 |
Oncolytic Adenovirus (Capsid modified Ad5, phTERT-Δ19k, Anti-ERBB2-2), Viral particle |
| CAR-T-2-L337-2Z |
Anti-ErbB2 scFv h(CD28-CD3ζ) CART, pCDCAR1 |
| OAdCmodV-YX0981 |
Oncolytic Adenovirus (Capsid modified Ad5, pCMV-Δ55k, Anti-ERBB2-4), Viral particle |
| CAR-LC172 |
Anti-HER2 (4D5) h(41BB-CD3ζ) CAR, pCDCAR1 |
| CAR-MZ033 |
Anti-ErbB2 (C6.5G98A) h(CD28-CD3ζ) CAR, pCDCAR1 |
| TCR-L227 |
Human anti-Her2 T cell receptor (E2), pCDTCR1 |
| VP-CAR-LC230 |
Lenti-ErbB2 CAR (scFv-b2c-CD3ζ, OTI5C4) Viral Particle |
| OAdCmodV-YX1017 |
Oncolytic Adenovirus (Capsid modified Ad5, phTERT-Δ24/55k, Anti-ERBB2-4), Viral particle |
| CAR-MZ134 |
Anti-ErbB2 (4D5 ) h(CD28-CD3ζ) CAR, pCDCAR1 |
| CAR-MZ029 |
Anti-ErbB2 (C6-B1D2) h(CD28-CD3ζ) CAR, pCDCAR1 |
Oncolytic VirusCarcinomaOthers
Kits for CARs/TCRs Development 
Datasheet
Subscribe to Our Newsletter for Updates: